Preference Attributes of ELLIPTA Dry Powder Inhaler (DPI) and HANDIHALER DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT02786927 · COMPLETED
Trial details
- NCT number
- NCT02786927
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-21
- Primary completion
- 2016-10-04
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.